SCHEMBL4635207

SCHEMBL4635207

CCCOC1(O)C=CC=CC1C(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
ALDH1A1 P00352 6/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HSD17B10 Q99714 2/20 0.38
NPC1 O15118 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KMT2A Q03164 2/20 0.34
CES2 O00748 3/20 0.33
CES1 P23141 3/20 0.33
KDM4E B2RXH2 1/20 0.32
HTT P42858 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KCNH2 Q12809 1/20 0.32
MMP9 P14780 1/20 0.32
MMP8 P22894 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7386572 0.89 NPC1 (0.37) LMNAALDH1A1HSD17B10NPC1L3MBTL1
SCHEMBL9403246 0.88 GAA (0.36) ALDH1A1HSD17B10NPC1L3MBTL1HTT
SCHEMBL12005276 0.83 KDM4E (0.32) LMNANPSR1NPC1L3MBTL1KDM4E
SCHEMBL5150393 0.83 KMT2A (0.40) LMNAALDH1A1HSD17B10NPC1L3MBTL1
SCHEMBL820868 0.82 NPC1 (0.37) ALDH1A1HSD17B10NPC1L3MBTL1KMT2A
SCHEMBL2805922 0.82 NPC1 (0.40) ALDH1A1HSD17B10NPC1L3MBTL1KMT2A
SCHEMBL17394347 0.81 CYP3A4 (0.34) LMNAALDH1A1HSD17B10NPC1L3MBTL1
SCHEMBL14813391 0.77 NPC1 (0.38) LMNAALDH1A1HSD17B10NPC1L3MBTL1
SCHEMBL28737678 0.77 NPC1 (0.38) LMNAALDH1A1NPSR1HSD17B10NPC1
SCHEMBL29091452 0.76 NPC1 (0.40) LMNAALDH1A1HSD17B10NPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260000076-A1 ANTIMICROBIAL COMBINATIONS CLARIANT INT LTD (CH) 2026-01-01 US disclosed
EP-4637352-A2 ANTIMICROBIAL COMBINATIONS CLARIANT INTERNATIONAL LTD (CH) 2025-10-29 EP disclosed
EP-4245293-B1 USE OF SUGAR AMINES AS COMPLEXING AGENTS CLARIANT INT LTD (CH) 2025-08-06 EP disclosed
EP-4557953-A1 ANTIMICROBIAL COMBINATIONS CLARIANT INTERNATIONAL LTD (CH) 2025-05-28 EP disclosed
CN-119997951-A Method for preventing, alleviating and/or treating PTGS 2-induced skin disorders and related dysfunctions 西姆莱斯股份公司 2025-05-13 CN disclosed
CN-119968452-A Perfume mixture (VI) 西姆莱斯股份公司 2025-05-09 CN disclosed
EP-3735827-B1 COMPOSITION FOR INHIBITING MICRO-ORGANISMS CLARIANT INT LTD (CH) 2025-04-09 EP disclosed
CN-119790128-A Perfume mixture (III) 西姆莱斯股份公司 2025-04-08 CN disclosed
EP-3554646-B1 WATER-SOLUBLE AND/OR WATER-SWELLABLE HYBRID POLYMER CLARIANT INT LTD (CH) 2025-03-19 EP disclosed
EP-3554643-B1 WATER-SOLUBLE AND/OR WATER-SWELLABLE HYBRID POLYMER CLARIANT INT LTD (CH) 2025-03-19 EP disclosed
EP-4018994-A1 COMPOSITION COMPRISING OILS, FREE FATTY ACIDS AND SQUALENE Clariant International Ltd (CH) 2022-06-29 EP disclosed
WO-2022122719-A1 ESTOLIDE ESTERS FOR THE COSMETIC TREATMENT OF SKIN CLARIANT INTERNATIONAL LTD (CH) 2022-06-16 WO disclosed
CN-112334125-B Cosmetic preparation 花王株式会社 2022-06-10 CN disclosed
EP-4008406-A1 COSMETIC COMPOSITION BASED ON ACROYL TAURATE TYPE POLYMERS Clariant International Ltd (CH) 2022-06-08 EP disclosed
US-11339241-B2 Water-soluble and/or water-swellable hybrid polymer CLARIANT INTERNATIONAL LTD. (CH) 2022-05-24 US disclosed
US-11306170-B2 Water-soluble and/or water-swellable hybrid polymer CLARIANT INTERNATIONAL LTD. (CH) 2022-04-19 US disclosed
CN-114340585-A Solid cosmetic 信越化学工业株式会社 2022-04-12 CN disclosed
CN-108623809-B Organic group-modified silicone resin, method for producing same, and cosmetic 信越化学工业株式会社 2022-03-15 CN disclosed
EP-1928400-A2 SKIN CARE COMPOSITION COMPRISING INTERFERENCE PIGMENTS The Procter and Gamble Company (US) 2008-06-11 EP disclosed
WO-2007031970-A2 SKIN CARE COMPOSITION COMPRISING INTERFERENCE PIGMENTS THE PROCTER & GAMBLE COMPANY (US) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11339241-B2 Water-soluble and/or water-swellable hybrid polymer PWWP2B, CD44, ALG1 LMNA 2991/4885ALDH1A1 2695/4885NPSR1 3326/4885
US-20260000076-A1 ANTIMICROBIAL COMBINATIONS FFAR1, ELOVL3, ACAD11 LMNA 3287/4885ALDH1A1 1596/4885NPSR1 1018/4885
US-11306170-B2 Water-soluble and/or water-swellable hybrid polymer ALG1, CD44, PWWP2B LMNA 2777/4885ALDH1A1 1296/4885NPSR1 2766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.